CEA Kit ELISA

N° du produit ABIN5068372

Ce kit ELISA Colorimetric est destiné à la mesure quantitative de Humain CEA.

Aperçu rapide pour CEA Kit ELISA (ABIN5068372)

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Application: ELISA

Type d'échantillon: Serum

Détail du produit CEA Kit ELISA

Réactivité croisée (Details): Calculated cross reactivity: Hu

Sensibilité: > 0.72 ng/mL

Attributs du produit: Carcinoembryonic Antigen, Human ELISA Kit (CEA)

Ingrédients:

• 1. CEA Microtiter Plate, 1x96 wells
• 2. Ab (HRP), 1x12ml
• 3. CEA Standard - 160ng, 1x1 vial
• 4. CEA Standard - 80ng, 1x1 vial
• 5. CEA Standard - 40ng, 1x1 vial
• 6. CEA Standard - 20ng, 1x1 vial
• 7. CEA Standard - 10ng, 1x1 vial
• 8. CEA Standard - 5ng, 1x1 vial
• 9. CEA Standard - 2.5ng, 1x1 vial
• 10. CEA Standard - 0ng, 1x1 vial
• 11. Substrate A, 1x10ml
• 12. Substrate B, 1x10ml
• 13. Stop Solution, 1x15ml
• 14. Wash Buffer (20X), 1x60ml

Information d'application

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Stockage commentaire: 4°C

Détail du antigène

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Autre désignation: Carcinoembryonic Antigen

Sujet: Carcinoembryonic Antigen (CEA) is a 180-200kD glycoprotein expressed at high level in the epithelial cells of the embryonic colon. The expression is stopped after birth. CEA serum content is low in normal population and only slightly elevated in heavy smokers. Increased serum CEA level was found associated with colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, lung carcinoma, and breast carcinoma (3, 4, 5, 6). CEA has been used as a biomarker for carcinoma. However elevated CEA level not necessarily indicates neoplastic conditions, since high CEA expression has been observed in non-neoplastic conditions such as ulcerative colitis, pancreatitis and cirrhosis. Clinically, CEA level is mainly used to monitor the tumor recurrence after surgical resection of carcinoma (1, 2, 7).